Methods and devices for the treatment of ocular diseases in human subjects
US12350261B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 7, 2021 |
| Grant date | Jul 8, 2025 |
| Priority date | — |
| Expiry date | Jul 8, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2037/0061
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.